WHO ICTRP trial
A double-blind, randomised, placebo-controlled clinical study to evaluate the…
EUCTR2016-000540-33-HU · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2016-000540-33-HU |
|---|---|
| Public title | A double-blind, randomised, placebo-controlled clinical study to evaluate the efficacy and safety of N-Acetyl-GED-0507-34-LEVO gel, 1 and 2%, applied once daily for 12 weeks in patients with mild to moderate facial acne vulgaris |
| Scientific title | A double-blind, randomised, placebo-controlled clinical study to evaluate the efficacy and safety of N-Acetyl-GED-0507-34-LEVO gel, 1 and 2%, applied once daily for 12 weeks in patients with mild to moderate facial acne vulgaris - N-Acetyl-GED-0507-34-Levo facial acne |
| Primary sponsor | PPM Services S.A. |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): yes Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): no |
| Countries | Hungary;Hungary;Hungary |
| Conditions | facial acne vulgaris MedDRA version: 18.1 Level: LLT Classification code 10000519 Term: Acne vulgaris System Organ Class: 100000004858 ;Therapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17];facial acne vulgaris MedDRA… |
| Interventions | Product Name: N-Acetyl-GED-0507-34-Levo 1% Pharmaceutical Form: Gel INN or Proposed INN: Not yet available. CAS Number: 1190427-41-8 Current Sponsor code: N-Acetyl-GED-0507-34-Levo Concentration unit: % (W/W) percent weight/weight… |
| Registration date | Dec 4, 2016 |
| Target size | 144 |
| Secondary IDs | GED-0507-ACN-01-16;GED-0507-ACN-01-16;GED-0507-ACN-01-16 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: